These Analysts Boost Their Forecasts On DuPont After Upbeat Results

DuPont de Nemours Inc. DD posted better-than-expected first-quarter 2025 results on Friday.

The company reported sales growth of 5% year-over-year to $3.07 billion, beating the consensus of $3.04 billion. Organic sales increased by +6% YoY, with an 8% volume boost offset by 2% lower prices. Electronics, healthcare and water drove volume gains. Adjusted EPS for the quarter was $1.03 (+30% YoY), beating the consensus of $0.79.

"We continue to benefit from ongoing strength in electronics markets as well as strong demand in healthcare and water end-markets. Through April, we continued to see strong order patterns consistent with our expectations," said Lori Koch, DuPont's CEO.

For the second quarter, DuPont expects net sales of ~$3.20 billion versus the consensus of $3.25 billion and Adjusted EPS of ~$1.05 versus the consensus of $1.08.

DuPont said it sees 2025 adjusted EPS of $4.30–$4.40 versus the $4.34 consensus and expects revenue of $12.8 billion-$12.9 billion versus the $12.92 billion consensus.

DuPont shares fell 0.8% to trade at $66.72 on Monday.

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.

These analysts made changes to their price targets on DuPont following earnings announcement.

Morgan Stanley analyst Vincent Andrews maintained DuPont de Nemours with an Equal-Weight rating and lowered the price target from $94 to $80.
Keybanc analyst Aleksey Yefremov maintained DuPont with an Overweight rating and raised the price target from $81 to $85.

Considering buying DD stock? Here’s what analysts think: